|
Title
|
Published
|
Price
|
|
Freedonia Focus on Cancer Therapies
By: Freedonia Focus
This report discusses US demand for cancer therapies for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, types of cancer, diagnosis and screening, technology
|
more...
|
11/30/2009
|
$500.00
|
|
GlaxoSmithKline (GSK) Profile & Health Care Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Health Care Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends affecting
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Eli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Pfizer Inc (PFE) Profile & Biotech Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Roche Holding LTD (RHHBY) Profile & Health Care Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Health Care Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends affecting
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Novartis (NVS) Profile & Health Care Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Health Care Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends affecting
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Walgreen Co (WAG) Profile & Health Care Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Health Care Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends affecting
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Sanofi-Aventis SA (SNY) Profile & Biotech Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
Merck & Co Inc. (MRK) Profile & Biotech Industry Trends Analysis 2010
By: Plunkett Research, Ltd.
This summary contains complete trends chapters excerpted from Plunkett's Biotech & Genetics Industry Almanac. Wield this tool for strategic planning, business development, or industry analysis. It includes our analysis of the major trends
|
more...
Search inside this report
|
11/18/2009
|
$149.99
|
|
United States Type 2 Diabetes Market
By: Intellent
Intellent's new industry report focuses on the US type 2 diabetes market. This report provides valuable insight and access to the competitive information and analysis necessary to make decisions regarding the direction of the market
|
more...
Search inside this report
|
11/14/2009
|
$7,500.00
|
|
Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
By: Datamonitor
Introduction
Courtesy of the patent cliff, the pharmaceutical industry is set for a dramatic slow down in revenue growth from 2011. Industry players are therefore looking to implement strategies which will cushion them against the
|
more...
|
11/12/2009
|
$7,600.00
|
|
Snapshots Venezuela Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Venezuela Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Venezuelan pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Spain Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Spain Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Spanish pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots South Africa Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots South Africa Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the South African pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Poland Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Poland Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Polish pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Hungary Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Hungary Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Hungarian pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US Nasal Products 2009
By: Snapdata International Group
Snapdata's Snapshots US Nasal Products 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US nasal product
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US OTC Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US OTC pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots Denmark OTC Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots Denmark OTC Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Danish OTC pharmaceutical
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Snapshots US Pharmaceuticals 2009
By: Snapdata International Group
Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and
|
more...
Search inside this report
|
11/12/2009
|
$600.00
|
|
Company Financials: Bayer AG
By: Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
|
more...
|
11/10/2009
|
$75.00
|
|
Thailand Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Nigeria’s pharmaceutical market in 2008 was NGN80.9bn (US$680mn). We forecast a12.8% year-on-year (y-o-y) growth in local currency during 2009, expecting that the market will grow bya compound annual growth rate (CAGR) of
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Poland Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is adestination for almost all multinationals operating within the region. Poland’s pharmaceutical market hasshown consistently strong growth
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Argentina Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. BMI’s updated forecasts see themarket reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of12.68% in US dollar terms. With
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Title
|
Published
|
Price
|
(0 items)
